ClinicalTrials.gov
ClinicalTrials.gov Menu

Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00301015
Recruitment Status : Completed
First Posted : March 10, 2006
Last Update Posted : November 1, 2007
Sponsor:
Collaborator:
Muhimbili University of Health and Allied Sciences
Information provided by:
Karolinska University Hospital

Brief Summary:

The purpose of this study is to evaluate the efficiency of a rapid diagnostic test (Paracheck Pf) for the diagnosis of uncomplicated Plasmodium falciparum malaria by community health workers at village level in Tanzania and how the use of rapid diagnostic test may influence prescription of antimalarial drugs.

The hypothesis is that rapid diagnostic tests used by community health workers will reduce the use of antimalarial drugs (Coartem; Novartis) by 30% without affecting the health outcome.


Condition or disease Intervention/treatment Phase
Uncomplicated Plasmodium Falciparum Malaria Device: Rapid diagnostic test for malaria Phase 4

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 3005 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers
Study Start Date : March 2006
Actual Study Completion Date : August 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Malaria
U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Malaria diagnosis aided with rapid diagnostic test
Device: Rapid diagnostic test for malaria
We used Paracheck Pf® (Orchid Biomedical Systems, India) as rapid diagnostic test in this trial
Active Comparator: 2
Malaria diagnosis based on clinical judgement only
Device: Rapid diagnostic test for malaria
We used Paracheck Pf® (Orchid Biomedical Systems, India) as rapid diagnostic test in this trial



Primary Outcome Measures :
  1. Number of patients with fever prescribed artemether-lumefantrine for the treatment of malaria in respective study groups [ Time Frame: 28 days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Fever
  • Informed consent

Exclusion Criteria:

  • Severe clinical manifestations, which require immediate referral
  • Pregnancy
  • Previous enrollment in the study within the last 28 days

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00301015


Locations
Tanzania
Villages
Kibaha, Kibaha District, Tanzania
Sponsors and Collaborators
Karolinska University Hospital
Muhimbili University of Health and Allied Sciences
Investigators
Study Director: Anders Björkman, MD, PhD Dept of Medicine, Karolinska University Hospital, 171 76 Stockholm, Sweden

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00301015     History of Changes
Other Study ID Numbers: RapAct 28-02-2006
First Posted: March 10, 2006    Key Record Dates
Last Update Posted: November 1, 2007
Last Verified: October 2007

Additional relevant MeSH terms:
Malaria
Malaria, Falciparum
Protozoan Infections
Parasitic Diseases
Artemisinins
Artemisinine
Antimalarials
Antiprotozoal Agents
Antiparasitic Agents
Anti-Infective Agents